Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes

被引：0

作者：

Pamela C. Heaton

Vibha C. A. Desai

Christina M. L. Kelton

Swapnil N. Rajpathak

机构：

[1] University of Cincinnati Academic Health Center,Pharmacy Practice and Administrative Sciences, James L. Winkle College of Pharmacy

[2] HealthCore,Carl H. Lindner College of Business

[3] University of Cincinnati,undefined

[4] US Outcomes Research,undefined

[5] Merck & Co.,undefined

[6] Inc.,undefined

来源：

BMC Endocrine Disorders | / 16卷

关键词：

Sulfonylureas; Oral antihyperglycemic agents; Type 2 diabetes; Hospital readmissions;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Sulfonylurea Use and Risk of Coronary Heart Disease among Patients with Type 2 Diabetes: A Prospective Cohort Study among Women
Li, Yanping
Hu, Yang
Rajpathak, Swapnil
Hu, Frank B.
DIABETES, 2014, 63 : A372 - A372
[22] ExenatideA Review of Its Use in Patients with Type 2 Diabetes Mellitus (as an Adjunct to Metformin and/or a Sulfonylurea)
Risto S. Cvetković
Greg L. Plosker
Drugs, 2007, 67 : 935 - 954
[23] Combination therapy with pioglitazone and sulfonylurea in patients with type 2 diabetes
Schneider, R
Egan, J
Houser, V
DIABETES, 1999, 48 : A106 - A106
[24] Exenatide: A guide to its use as an adjunct to metformin and/or a sulfonylurea in patients with type 2 diabetes mellitus
不详
Drugs & Therapy Perspectives, 2007, 23 (10) : 5 - 8
[25] Exenatide - A review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea)
Cvetkovic, Risto S.
Plosker, Greg L.
DRUGS, 2007, 67 (06) : 935 - 954
[26] Absorption of sulfonylurea drugs in patients with Type 2 Diabetes mellitus
Kopp, HP
Melander, A
Krugluger, W
Hopmeier, P
Schernthaner, G
DIABETOLOGIA, 1996, 39 : 872 - 872
[27] Glycemic response to exercise among obese patients with type 2 diabetes: Impact of sulfonylurea use
Dasgupta, K
Grover, S
Lowensteyn, I
Rahme, E
DIABETES, 2004, 53 : A460 - A460
[28] Risk of Heart Failure Hospitalization Associated with Glinide and Sulfonylurea Use in Type 2 Diabetes: A Nationwide Study
Chang, Chia-Hsuin
Lee, Yen-Chieh
Lin, Jou-Wei
Wu, Li-Chiu
Hwang, Jiang-Shiang
Chuang, Lee-Ming
DIABETES, 2016, 65 : A401 - A401
[29] Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
Rudakova, A. V.
DIABETES MELLITUS, 2011, 14 (03): : 111 - 112
[30] Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms
Aquilante, Christina L.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (03) : 359 - 372

← 1 2 3 4 5 →